PCM
AMGN icon

Peregrine Capital Management’s Amgen AMGN Stock Holding History

Peregrine Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,805
Closed -$713K – 339
2020
Q3 		$713K Buy
+2,805
New +$695K 0.02% 264

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Peregrine Capital Management's AMGN Position: Q4 2020 in Review

Peregrine Capital Management sold out of Amgen (AMGN) in Q4 2020, closing a stake of 2,805 shares — an estimated $713K sold.

Peregrine Capital Management first reported a position in AMGN in Q3 2020 and held it in 1 quarter. The position peaked at $713K in Q3 2020. 2,219 funds tracked by Wall St. Rank hold AMGN as of Q4 2020.

  • Peregrine Capital Management reported no remaining Amgen position as of Q4 2020 after selling out during the quarter.
  • Peregrine Capital Management sold 2,805 Amgen shares in Q4 2020, an estimated $713K.
  • Peregrine Capital Management first reported a position in Amgen in Q3 2020 and held it in 1 quarter.
  • Peregrine Capital Management's Amgen position peaked at $713K in Q3 2020.
  • 2,219 funds tracked by Wall St. Rank held Amgen as of Q4 2020.

Based on Peregrine Capital Management's 13F filing for Q4 2020, filed 19 Jan 2021.